Wolf.” for treating AIH, including quercetin, kaempferol, naringenin, licochalcone A, and formononetin, and TP53, AKT1, JUN, STAT3, TNF, and IL-6 may be the key targets for these medicinal compositions. The gene discussed is AKT1; the disease is autoimmune hepatitis.